Can a simple change of location make pump refills less stressful?
NCT ID NCT07727798
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether having intrathecal pump refills at home is more comfortable than going to the hospital. Adults in Belgium with an implanted pump for chronic pain or severe spasticity will each receive two refills at home and two at the hospital, in random order. The study measures comfort, quality of life, and patient preference to see if home-based care could ease the burden of these regular procedures.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- intrathecal pump refill procedure
- What this could lead to
- If home refills prove more comfortable, this could reduce stress and travel burden for patients who need regular pump maintenance.
- What could go wrong
- This is a small crossover trial; home refills may not be suitable for everyone and safety data are still limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 82 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Actively receiving Intrathecal drug delivery * Stable medication dosage for at least 3 months * Dutch, French or English speaking adults Exclusion Criteria: * Life expectancy \< 6 months * Patients planned for but not yet received Intrathecal drug delivery implant * No residence in Belgium
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intrathecal pump refill are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
UZ Brussel
RECRUITINGJette, 1090, Belgium